Feasibility of a cardiovascular cohort in a Sub-Saharan Africa community: preliminary report of the pilot project TAHES (Tanvè Health Study) in Benin

Abstract

Background: Faced with the growing burden of cardiovascular disease (CVD) including atherosclerotic in Sub-Saharan Africa (SSA), the development of appropriate prediction tools, based on large cohorts, appears useful for prevention. Objective: The objective of the pilot project TAHES (Tanvè Health Study) was to explore the feasibility of a large cohort study focused on CVD and risk factors in Benin. Methods: We implemented a prospective cohort over 2 years. The sample consisted of all people aged 25 years or older who had lived for at least the previous 6 months in the villages of Tanvè or Dékanmè. At baseline in February 2015, behaviours and medical histories were recorded using a standardized questionnaire adapted from the WHO Steps instrument; screening questionnaires for angina, claudication, congestive heart failure, and stroke were applied; anthropometric measures and fasting capillary blood glucose were taken. All participants were included in the follow-up phase. Surveillance of target CVD and deaths was implemented through a medical and a community network. Results: A total of 1,195 participants were enrolled at baseline; women represented 65.5% and the median age was 39 years. The high participation rate (91.4%), the quality of baseline data, and the functionality of the events surveillance network over 8 months indicated good perspective for the feasibility of a large cohort. We recorded a 3.8% prevalence of daily smoking, 3.6% of harmful use of alcohol, 10.7% of obesity, 25.5% of high blood pressure, and 3.5% of diabetes. Prevalence of angina pectoris (2.7%), intermittent claudication (2.0%), congestive heart failure (0.9%), and stroke survival with motor impairment (3‰) were also recorded. Ten deaths occurred during the first 8 months, all within households; a cardiovascular cause was suspected in four cases. Conclusion: These preliminary results support the feasibility of establishing a cohort in Benin. It would require technical and resource support.

The prevalence, awareness, management and control of hypertension in men and women in Benin, West Africa: the TAHES study

“…This is an analysis of inclusion data collected in the TAnve HEalth Study (TAHES) a prospective population-based cohort study initiated in 2015 in Tanve, a rural setting 150 km north of Cotonou, the capital of Benin. The TAHES involved all adults above 25 years old living in Tanve [9]. Its main objective is to assess the frequency of CVDs and their associated risk factors.…”

Diabetes and correlates of cardiovascular diseases among women aged 15-49 years in Benin: evidence from a Demographic and Health Survey

“…Unfortunately, data on the estimates of complications and deaths as a result of lung diseases in most SSA countries are often not available as routine vital registrations are habitually not available (9,10). However, in a project conducted in Benin on hearts-related NCDs shows that risk factors for CVDs such as high blood pressure and obesity were 35.5% and 10.7% respectively, among the studied population, with crude mortality rate of 12.5 for every 1,000 person-year (12). A comprehensive knowledge and understanding of these trends in changes in global health status and the foremost causes of burden of diseases is critical to the achievement of the third Sustainable Development Goal…”

Normal values of proximal aorta diameters in healthy Sub Saharan Africans: The TAHES study

“…The main objective of this project was to develop an appropriate screening tool to identify people at risk of cardiovascular diseases in Benin, applicable to other similar SSA populations. Details on the initial phase of the cohort study have been published elsewhere 4 …”

“…Details on the initial phase of the cohort study have been published elsewhere. 4 During the third annual visit in 2017, TTE was proposed in addition to the usual data collection. All the residents (≥6 months, all blacks) in the study area aged 25 years or older were eligible.…”